EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
HSHP
Himalaya Shipping Ltd.
There isn't enough reported data to score HSHP yet.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HSHP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Weak |
HSHP's profitability is currently strong, but its balance sheet is weak. There isn't enough data to rate its revenue and cash flow.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
HSHP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $16.13 | — |
| Cheap | 14x | $16.08 | -0.3% |
| Current | 14x | $16.13 | — |
| Fair | 38x | $43.30 | +168% |
| Expensive | 188x | $212 | +1216% |
Historical ranges are pointers, not guarantees.
HSHP's PE is 14x, but its earnings don't support one, so it isn't a reliable read right now.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HSHP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HSHP's earnings and revenue to decline, with profitability weakening.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
HSHP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.30 | +15% |
| Q2 2026 | $1.13 | +653% |
| Q4 2025 | $0.38 | -21% |
| Q4 2024 | $0.48 | +1100% |
| Q4 2023 | $0.04 | +$0.10 |
HSHP has the edge over EOSE in the latest year-over-year earnings comparison.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over HSHP in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
HSHP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $87.3M | +68% |
| Q4 2025 | $80M | +16% |
| Q2 2025 | $51.9M | -5.3% |
| Q4 2024 | $68.8M | +87% |
HSHP's revenue has grown year over year for six quarters in a row: $87M last quarter, up 59% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 62% | +8.9 points |
| Q4 2025 | 60% | +20 points |
| Q2 2025 | 39% | N/A |
| Q4 2024 | 55% | N/A |
| Q2 2024 | 53% | N/A |
| Q4 2023 | 40% | N/A |
HSHP has the edge over EOSE on profitability, with a higher operating margin.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
HSHP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2022 | -$15.5M | +$26.2M |
| Q2 2022 | -$14.9M | -$14.9M |
HSHP and EOSE do not have enough comparable growth data to identify a winner.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HSHP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.6% | +1.2M shares |
| 1 year | +7.6% | +3.3M shares |
HSHP has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HSHP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.9x | High |
| Q4 2025 | 6.7x | High |
| Q2 2025 | 7.8x | High |
| Q4 2024 | 7.5x | High |
| Q4 2023 | 17.4x | High |
HSHP's net debt is about 4.9 years of its operating earnings (EBITDA), down from 17 years a year ago.
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HSHP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 28.1 | Neutral |
HSHP's weekly RSI is 51 (neutral) and its Stochastic is 28 (neutral).
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
HSHP PE vs Industrials Sector
| Metric | HSHP | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 24x | 41% below |
| PE % | 18 | 59 | 41 pts below |
HSHP is trading at 14x earnings, a 41% discount to the Industrials sector's median of 24x, though its earnings don't support one.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
HSHP has stronger trend alignment. EOSE is above 0 of 5 weekly averages versus HSHP above 2 of 4.
HSHP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.8 | 4% below |
| 20 week MA | $16.6 | 2.6% below |
| 50 week MA | $14.1 | 15% above |
| 100 week MA | $10.3 | 57% above |
HSHP has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 57% above its 100-week average.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.
HSHP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $5.80 | $6.76 | +17% |
| 2024 | $6.76 | $4.85 | -28% |
| 2025 | $4.85 | $8.96 | +85% |
| 2026 YTD | $8.96 | $16.1 | +80% |
HSHP has the edge over EOSE on returns for 2026, with the stronger performance.